ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell therapy enters human testing for Tough-to-Treat kidney cancer
Disease control OngoingThis early-stage trial is testing the safety and finding the right dose of an experimental cell therapy called ALLO-316 for people with advanced kidney cancer that has spread. The study involves 120 adults whose cancer has progressed despite standard treatments. Researchers are g…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 06:20 UTC
-
Personalized 'Living Drug' trial targets Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing a new cell therapy called AB-2100 for people with advanced kidney cancer that has come back or spread after standard treatments. Doctors take a patient's own immune cells, genetically modify them to better recognize and attack cancer, and infuse them back in…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC